Alberto Goffi

Alberto Goffi

Auto-generated profile, based on publicly available information

Alberto Goffi

Department of Medicine and Interdepartmental Division of Critical Care Medicine, University of Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Chest
Verified
Journal Article
Closed access
EPEmanuele Pivetta
Emanuele Pivetta
AGAlberto Goffi
Alberto Goffi
ELEnrico Lupia
Enrico Lupia
MTMaria Tizzani
Maria Tizzani
GPGiulio Porrino
Giulio Porrino
ERElisa Romagnoli
Elisa Romagnoli

14 January 2020 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
PTPieter R. Tuinman
Pieter R. Tuinman
AJAnnemijn H. Jonkman
Annemijn H. Jonkman
MDMartin Dres
Martin Dres
ZSZhong-Hua Shi
Zhong-Hua Shi
EGEwan C. Goligher
Ewan C. Goligher
LHLeo Heunks
Leo Heunks
Respiratory muscle ultrasound is used to evaluate the anatomy and function of the respiratory muscle pump. It is a safe, repeatable, accurate, and non-invasive bedside technique that can be successfully applied in different settings, including general intensive care and the emergency department. Mastery of this technique allows the intensivist to rapidly diagnose and assess respiratory muscle dysfunction in critically ill patients and in patients with unexplained dyspnea. Furthermore, it can be used to assess patient–ventilator interaction and weaning failure in critically ill patients. This paper provides an overview of the basic and advanced principles underlying respiratory muscle ultrasound with an emphasis on the diaphragm. We review different ultrasound techniques useful for monitoring of the respiratory muscle pump and possible therapeutic consequences. Ideally, respiratory muscle ultrasound is used in conjunction with other components of critical care ultrasound to obtain a comprehensive evaluation of the critically ill patient. We propose the ABCDE-ultrasound approach, a systematic ultrasound evaluation of the heart, lungs and respiratory muscle pump, in patients with weaning failure.

28 January 2019 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
EPEmanuele Pivetta
Emanuele Pivetta
AGAlberto Goffi
Alberto Goffi
PNPeiman Nazerian
Peiman Nazerian
DCDavide Castagno
Davide Castagno
CTCamilla Tozzetti
Camilla Tozzetti
OHon behalf of the Study Group on Lung Ultrasound from the Molinette and Careggi Hospitals
on behalf of the Study Group on Lung Ultrasound from the Molinette and Careggi Hospitals

25 April 2019 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
CRChiara Robba
Chiara Robba
AGAlberto Goffi
Alberto Goffi
TGThomas Geeraerts
Thomas Geeraerts
DCDanilo Cardim
Danilo Cardim
GVGabriele Via
Gabriele Via
GCGiuseppe Citerio
Giuseppe Citerio

23 January 2016 in Critical Care
Verified
Journal Article
Open access
PDF file
AMAirton Leonardo de Oliveira Manoel
Airton Leonardo de Oliveira Manoel
AGAlberto Goffi
Alberto Goffi
TMTom R. Marotta
Tom R. Marotta
TSTom A. Schweizer
Tom A. Schweizer
SASimon Abrahamson
Simon Abrahamson
RMR. Loch Macdonald
R. Loch Macdonald
Aneurysmal subarachnoid haemorrhage is a neurological syndrome with complex systemic complications. The rupture of an intracranial aneurysm leads to the acute extravasation of arterial blood under high pressure into the subarachnoid space and often into the brain parenchyma and ventricles. The haemorrhage triggers a cascade of complex events, which ultimately can result in early brain injury, delayed cerebral ischaemia, and systemic complications. Although patients with poor-grade subarachnoid haemorrhage (World Federation of Neurosurgical Societies 4 and 5) are at higher risk of early brain injury, delayed cerebral ischaemia, and systemic complications, the early and aggressive treatment of this patient population has decreased overall mortality from more than 50 % to 35 % in the last four decades. These management strategies include (1) transfer to a high-volume centre, (2) neurological and systemic support in a dedicated neurological intensive care unit, (3) early aneurysm repair, (4) use of multimodal neuromonitoring, (5) control of intracranial pressure and the optimisation of cerebral oxygen delivery, (6) prevention and treatment of medical complications, and (7) prevention, monitoring, and aggressive treatment of delayed cerebral ischaemia. The aim of this article is to provide a summary of critical care management strategies applied to the subarachnoid haemorrhage population, especially for patients in poor neurological condition, on the basis of the modern concepts of early brain injury and delayed cerebral ischaemia.

18 September 2016 in Critical Care
Verified
Journal Article
Open access
PDF file
AMAirton Leonardo de Oliveira Manoel
Airton Leonardo de Oliveira Manoel
AGAlberto Goffi
Alberto Goffi
FZFernando Godinho Zampieri
Fernando Godinho Zampieri
DTDavid Turkel-Parrella
David Turkel-Parrella
ADAbhijit Duggal
Abhijit Duggal
SASimon Abrahamson
Simon Abrahamson
Spontaneous intracerebral hemorrhage (ICH), defined as nontraumatic bleeding into the brain parenchyma, is the second most common subtype of stroke, with 5.3 million cases and over 3 million deaths reported worldwide in 2010. Case fatality is extremely high (reaching approximately 60 % at 1 year post event). Only 20 % of patients who survive are independent within 6 months. Factors such as chronic hypertension, cerebral amyloid angiopathy, and anticoagulation are commonly associated with ICH. Chronic arterial hypertension represents the major risk factor for bleeding. The incidence of hypertension-related ICH is decreasing in some regions due to improvements in the treatment of chronic hypertension. Anticoagulant-related ICH (vitamin K antagonists and the newer oral anticoagulant drugs) represents an increasing cause of ICH, currently accounting for more than 15 % of all cases. Although questions regarding the optimal medical and surgical management of ICH still remain, recent clinical trials examining hemostatic therapy, blood pressure control, and hematoma evacuation have advanced our understanding of ICH management. Timely and aggressive management in the acute phase may mitigate secondary brain injury. The initial management should include: initial medical stabilization; rapid, accurate neuroimaging to establish the diagnosis and elucidate an etiology; standardized neurologic assessment to determine baseline severity; prevention of hematoma expansion (blood pressure management and reversal of coagulopathy); consideration of early surgical intervention; and prevention of secondary brain injury. This review aims to provide a clinical approach for the practicing clinician.